Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis.

@article{vanGeffen2019SurgicalAE,
  title={Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis.},
  author={Wouter H. van Geffen and Dirk-Jan Slebos and Felix J.F. Herth and Samuel V. Kemp and Walter Weder and Pallav L. Shah},
  journal={The Lancet. Respiratory medicine},
  year={2019},
  volume={7 4},
  pages={
          313-324
        }
}
Bronchoscopic Lung Volume Reduction with Endobronchial Zephyr Valves for Severe Emphysema: A Systematic Review and Meta-Analysis
TLDR
In this population, Zephyr valves provided significant and clinically meaningful short-term improvements in either homogeneous or heterogeneous emphysema without CV but with an increase in adverse events.
Efficacy of the Spiration Valve System in Patients with Severe Heterogeneous Emphysema: A Systematic Review and Meta-Analysis
TLDR
In patients with severe heterogeneous emphysema and hyperinflation without CV, SVS is an alternative that showed an improvement in pulmonary function, quality of life, and dyspnea score with an acceptable risk profile.
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update.
TLDR
The treatment with one-way endobronchial valves has been investigated most extensively and more data are available regarding the treatment of more "marginal cases," or subsequent lung volume reduction surgery.
Lung Volume Reduction Surgery in Patients with Heterogenous Emphysema: Selecting Perspective
TLDR
Preoperative spirometry and body plethysmographic pulmonary function tests were useful measures to selected severe heterogenous emphysema patients for LVRS, and patients with FEV1 ≤ 50%, TLC in the range of 100-140% should be selected.
Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO
TLDR
Results showed statistically significant and clinically relevant improvements in lung function, exercise capacity, and quality of life up to 6 months after EBV treatment in emphysema patients with a DLCO ≤20% with no increased risk of serious adverse events.
5-Year Survival after Endobronchial Coil Implantation: Secondary Analysis of the First Randomised Controlled Trial, RESET
TLDR
Endobronchial coil implantation appears to confer a 5-year survival advantage for those who achieved a 10% reduction in RV at 3 months, and Ongoing trials are designed to clarify the mechanisms of action of coils and to refine patient selection.
Thermal Volume Reduction Surgery for Surgical Treatment of Pulmonary Bullae: A Single-Center Treatment Experience of 276 Cases Accompany With Primary Lung Cancer
TLDR
A new thermal-based surgical approach to treat pulmonary Bullae by reducing abnormally enlarged lung tissue in specific patients diagnosed with lung cancer accompany with pulmonary bullae is reported.
Bronchoscopic Lung Volume Reduction Using Endobronchial Valves: How to Do It
TLDR
EBVs are a viable treatment option, with manageable complications, for patients with COPD who have hyperinflation and refractory symptoms, when there is complete fissure integrity (no collateral ventilation).
...
...

References

SHOWING 1-10 OF 45 REFERENCES
Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.
TLDR
To assess the effects of BLVR on the short- and long-term health outcomes in participants with moderate to severe COPD and determine the effectiveness and cost-effectiveness of each individual technique, six studies were included.
Lung volume reduction surgery for diffuse emphysema.
TLDR
This review gathered all available evidence from randomised controlled trials comparing the effectiveness of lung volume reduction surgery (LVRS) versus non-surgical standard therapy in improving health outcomes for patients with severe diffuse emphysema to determine which surgical approaches for LVRS are most effective.
The IBV Valve Trial: A Multicenter, Randomized, Double-Blind Trial of Endobronchial Therapy for Severe Emphysema
TLDR
This trial had technical and statistical success but partial-bilateral endobronchial valve occlusion did not obtain clinically meaningful results and further studies need to focus on improved patient selection and a different treatment algorithm.
Lung Volume Reduction Surgery vs Medical Treatment: For Patients with Advanced Emphysema.
TLDR
Six months after randomization, LVRS produced better palliation than optimal medical therapy in patients with advanced emphysema, and was associated with a higher FEV(1) and lower residual volume.
Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema.
TLDR
Health-related quality of life showed significant postoperative improvement and with time correlated well with the improvement in forced expiratory volume in 1 second and the residual volume showed statistically significant improvements between preoperative values and each time point of follow-up.
Surgical approaches for lung volume reduction in emphysema.
TLDR
Concerns about surgical mortality should not discourage LVRS in selected patients with COPD, provided that it is undertaken within a multidisciplinary team environment involving appropriate patient selection.
Effect of lung-volume-reduction surgery in patients with severe emphysema.
TLDR
In selected patients with severe emphysema, lung-volume-reduction surgery can improve FEV1, walking distance, and quality of life and whether it reduces mortality is uncertain.
Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.
TLDR
In this preliminary study of patients with severe emphysema followed up for 6 months, bronchoscopic treatment with nitinol coils compared with usual care resulted in improved exercise capacity with high short-term costs.
A Multicenter Pilot Study of a Bronchial Valve for the Treatment of Severe Emphysema
TLDR
Bronchial valve treatment of emphysema has multiple mechanisms of action and acceptable safety, and significantly improves quality of life for the majority of patients, and suggests that there is improved ventilation and perfusion matching in non-UL lung parenchyma.
...
...